Related Experiment Video
Updated: Aug 15, 2026
The Double-H Maze: A Robust Behavioral Test for Learning and Memory in Rodents
Published on: July 8, 2015
Effects of a novel compound MCI-225 on impaired learning and memory in rats
Abstract:
Effects of MCI-225, [4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d]pyrimidine monohydrate hydrochloride] on experimental amnesia were studied in rats and compared with those of THA [9-amino-1,2,3,4-tetrahydroacridine]. In the Morris-type water maze task, MCI-225 (1-10 mg/kg, PO) reduced the spatial learning impairment induced by scopolamine (0.5 mg/kg, IP). In a passive avoidance (PA) task, administration of MCI-225 prior to training (1-30 mg/kg, PO) lessened the carbon dioxide (CO2)-induced amnesia in a dose-dependent manner. MCI-225 (1-100 mg/kg) did not affect gross behavior. THA (0.1-3 mg/kg, PO) reduced scopolamine-induced learning deficits in the water maze task, but the effect was not significant. THA (0.3-3 mg/kg, PO) also ameliorated the CO2-induced amnesia, although slightly, in the PA task. THA (10 mg/kg, PO) increased locomotor activity and higher dose of THA (30 mg/kg, PO) induced tremor, hypersalivation, and muscle relaxation. These results suggest that MCI-225 lessens impairments in learning and memory without causing serious behavioral abnormalities.
Insights
MCI-225 demonstrates potential in treating amnesia by reducing memory impairments in rats without causing adverse behavioral effects. This suggests MCI-225 is a promising therapeutic candidate for memory disorders.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Experimental amnesia models are crucial for evaluating potential cognitive enhancers.
- Scopolamine and carbon dioxide (CO2) are commonly used to induce amnesia in animal studies.
Purpose of the Study:
- To investigate the effects of MCI-225 on experimentally induced amnesia in rats.
- To compare the efficacy and safety of MCI-225 with THA (9-amino-1,2,3,4-tetrahydroacridine).
Main Methods:
- Rats were subjected to a Morris-type water maze task and a passive avoidance (PA) task to assess learning and memory.
- Amnesia was induced using scopolamine and CO2.
- MCI-225 and THA were administered orally (PO) at various doses.
Main Results:
- MCI-225 significantly reduced scopolamine-induced spatial learning deficits and CO2-induced amnesia in a dose-dependent manner.
- THA showed less significant effects in the water maze task and only slightly ameliorated amnesia in the PA task.
- MCI-225 did not cause significant behavioral abnormalities, whereas THA induced adverse effects at higher doses.
Conclusions:
- MCI-225 effectively lessens impairments in learning and memory in rat models of amnesia.
- MCI-225 exhibits a favorable safety profile compared to THA, with fewer behavioral side effects.
